These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6114766)

  • 1. Evidence for an inhibitory presynaptic component of neuroleptic drug action.
    de Belleroche JS; Bradford HF
    Br J Pharmacol; 1981 Mar; 72(3):427-33. PubMed ID: 6114766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The contrasting effects of neuroleptics on transmitter release from the nucleus accumbens and corpus striatum.
    de Belleroche JS; Neal MJ
    Neuropharmacology; 1982 Jun; 21(6):529-37. PubMed ID: 6125910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of presynaptic receptors in the release and synthesis of 3H-dopamine by slices of rat striatum.
    Westfall TC; Besson MJ; Giorguieff MF; Glowinski J
    Naunyn Schmiedebergs Arch Pharmacol; 1976; 292(3):279-87. PubMed ID: 181686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of neuroleptics on release of 3H-dopamine from slices of rat corpus striatum.
    Dismukes K; Mulder AH
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Mar; 297(1):23-9. PubMed ID: 16224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between the ability of some neuroleptics to enhance striatal [3H]dopamine release and their lipophilicity.
    Goosey MW; Doggett NS
    Biochem Pharmacol; 1983 Aug; 32(16):2411-6. PubMed ID: 6137221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The actions of antipsychotic drugs on dopamine receptors in the rat substantia nigra.
    Pinnock RD
    Br J Pharmacol; 1984 Apr; 81(4):631-5. PubMed ID: 6144343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single and repeated administration of neuroleptic drugs to rats: effects on striatal dopamine-sensitive adenylate cyclase and locomotor activity produced by tranylcypromine and L-tryptophan or L-Dopa.
    Heal DJ; Green AR; Boullin DJ; Grahame-Smith DG
    Psychopharmacology (Berl); 1976 Sep; 49(3):287-300. PubMed ID: 12527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in dopamine synthesis rate in the supersensitivity phase after treatment with a single dose of neuroleptics.
    Hyttel J
    Psychopharmacology (Berl); 1977 Jan; 51(2):205-7. PubMed ID: 14353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antipsychotic drugs: direct correlation between clinical potency and presynaptic action on dopamine neurons.
    Seeman P; Lee T
    Science; 1975 Jun; 188(4194):1217-9. PubMed ID: 1145194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increase of dopamine synthesis in synaptosomes from rats treated with neuroleptics or reserpine.
    Tissari AH
    Med Biol; 1982 Feb; 60(1):38-41. PubMed ID: 6121960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional selectivity of neuroleptic drugs: an argument for site specificity.
    Borison RL; Diamond BI
    Brain Res Bull; 1983 Aug; 11(2):215-8. PubMed ID: 6138135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopaminergic neurons: an in vivo system for measuring drug interactions with presynaptic receptors.
    Walters JR; Roth RH
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Dec; 296(1):5-14. PubMed ID: 13315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential actions of classical and atypical neuroleptics on mouse nigrostriatal neurons.
    Wood PL; McQuade PS; Etienne P; Lal S; Nair NP
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):765-8. PubMed ID: 6141617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Monoamine antagonism in relation to the direct effect of neuroleptics on the release of stimulating amino acid neuromediators].
    Kovalev GI; Prikhozhan AV; Raevskiĭ KS
    Farmakol Toksikol; 1990; 53(5):22-4. PubMed ID: 1979280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potassium-induced release of 14C-dopamine from synaptosomes of corpus striatum of rats: effects of morphine.
    Bosse A; Kuschinsky K
    Arzneimittelforschung; 1978; 28(11):2100-2. PubMed ID: 582913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroleptics have identical potencies in human brain limbic and putamen regions.
    Seeman P; Ulpian C
    Eur J Pharmacol; 1983 Oct; 94(1-2):145-8. PubMed ID: 6140171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic neuroleptic treatment: D2 dopamine receptor supersensitivity and striatal glutamatergic transmission.
    Calabresi P; De Murtas M; Mercuri NB; Bernardi G
    Ann Neurol; 1992 Apr; 31(4):366-73. PubMed ID: 1350190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical evidence for the presence of presynaptic receptors on dopaminergic nerve terminals.
    De Belleroche J; Bradford HF
    Brain Res; 1978 Feb; 142(1):53-68. PubMed ID: 626919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroleptic activity and dopamine-uptake inhibition in 1-piperazino-3-phenylindans.
    Bøgesø KP
    J Med Chem; 1983 Jul; 26(7):935-47. PubMed ID: 6134833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Swim-induced grooming in mice is mediated by a dopaminergic substrate.
    Chesher GB; Jackson DM
    J Neural Transm; 1981; 50(1):47-55. PubMed ID: 6110702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.